Crinetics Pharmaceuticals, Inc.

NasdaqGS:CRNX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 2.74 B

Share Price

USD 29.23

Avg Daily Volume

812,568

Change (1 day)

-0.14%

Change (1 year)

-44.47%

Change (YTD)

-42.83%

Crinetics Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -261.57 M

Crinetics Pharmaceuticals, Inc. Operating Cash Flow is USD -261.57 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 46.58% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Crinetics Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -178.44 M, a 25.33% change year over year.
Crinetics Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -142.38 M, a 73.50% change year over year.
Crinetics Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -82.06 M, a 17.46% change year over year.
Crinetics Pharmaceuticals, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -69.86 M, a 34.74% change year over year.